Migraine-Associated Vertigo: Diagnosis and Treatment

Yoon-Hee Cha

doi:10.1055/s-0030-1249225

Seminars in Neurology, Inhaltsverzeichnis

Semin Neurol 2010; 30(2): 167-174
DOI: 10.1055/s-0030-1249225

Migraine-Associated Vertigo: Diagnosis and Treatment

Yoon-Hee Cha¹

¹Department of Neurology, University of California Los Angeles, Los Angeles, California

Abstract

ABSTRACT

Migraine-associated vertigo has become a well-recognized disease entity diagnosed based on a clinical history of recurrent vertigo attacks unexplained by other central or peripheral otologic abnormalities, which occurs in the patient with a history of migraine headaches. There is no international agreement on what spectrum of symptoms should be covered under this diagnosis, or what terminology should be used. The headaches and vestibular symptoms of migraine-associated vertigo may not be temporally associated, which often obscures the association. Diagnostic tests usually show nonspecific abnormalities that are also seen in patients with migraine who do not experience vestibular symptoms. Management generally follows the recommended treatment of migraine headaches, and includes dietary and lifestyle modifications and medical treatment with β blockers, calcium channel blockers, and tricyclic amines. Small case series show that acetazolamide and lamotrigine appear to be more effective for the vertigo attacks than headaches. Vestibular rehabilitation has also been shown to be helpful in several studies. In this review, the epidemiologic and clinical features of the disorder, as well as the current state of knowledge on pathophysiology, diagnostic testing, and treatment are described.

KEYWORDS

Migraine - vertigo - vestibular - dizziness

Volltext

Referenzen

REFERENCES

1 Lee H, Sohn S I, Jung D K et al.. Migraine and isolated recurrent vertigo of unknown cause. Neurol Res. 2002; 24(7) 663-665
2 Cha Y H, Lee H, Santell L S, Baloh R W. Association of benign recurrent vertigo and migraine in 208 patients. Cephalalgia. 2009; 29(5) 550-555
3 Aragones J M, Fortes-Rego J, Fuste J, Cardozo A. Migraine: an alternative in the diagnosis of unclassified vertigo. Headache. 1993; 33(3) 125-128
4 Oh A K, Lee H, Jen J C, Corona S, Jacobson K M, Baloh R W. Familial benign recurrent vertigo. Am J Med Genet. 2001; 100(4) 287-291
5 Slater R. Benign recurrent vertigo. J Neurol Neurosurg Psychiatry. 1979; 42(4) 363-367
6 Lee H, Jen J C, Wang H et al.. A genome-wide linkage scan of familial benign recurrent vertigo: linkage to 22q12 with evidence of heterogeneity. Hum Mol Genet. 2006; 15(2) 251-258
7 Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): vestibular migraine?. J Neurology. 1999; 246 883-892
8 Bikhazi P, Jackson C, Ruckenstein M J. Efficacy of antimigrainous therapy in the treatment of migraine-associated dizziness. Am J Otol. 1997; 18(3) 350-354
9 Cutrer F M, Baloh R W. Migraine-associated dizziness. Headache. 1992; 32(6) 300-304
10 Brantberg K, Trees N, Baloh R W. Migraine-associated vertigo. Acta Otolaryngol. 2005; 125(3) 276-279
11 Savundra P A, Carroll J D, Davies R A, Luxon L M. Migraine-associated vertigo. Cephalalgia. 1997; 17(4) 505-510, discussion 487
12 Neuhauser H, Leopold M, von Brevern M, Arnold G, Lempert T. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology. 2001; 56(4) 436-441
13 Cass S P, Furman J M, Ankerstjerne K, Balaban C, Yetiser S, Aydogan B. Migraine-related vestibulopathy. Ann Otol Rhinol Laryngol. 1997; 106(3) 182-189
14 Neuhauser H K, von Brevern M, Radtke A et al.. Epidemiology of vestibular vertigo: a neurotologic survey of the general population. Neurology. 2005; 65(6) 898-904
15 Baier B, Stieber N, Dieterich M. Vestibular-evoked myogenic potentials in vestibular migraine. J Neurol. 2009; 256(9) 1447-1454
16 Celebisoy N, Gökçay F, Sirin H, Biçak N. Migrainous vertigo: clinical, oculographic and posturographic findings. Cephalalgia. 2008; 28(1) 72-77
17 Teggi R, Colombo B, Bernasconi L, Bellini C, Comi G, Bussi M. Migrainous vertigo: results of caloric testing and stabilometric findings. Headache. 2009; 49(3) 435-444
18 Baier B, Winkenwerder E, Dieterich M. “Vestibular migraine”: effects of prophylactic therapy with various drugs. A retrospective study. J Neurol. 2009; 256(3) 436-442
19 Vitkovic J, Paine M, Rance G. Neuro-otological findings in patients with migraine- and nonmigraine-related dizziness. Audiol Neurootol. 2008; 13(2) 113-122
20 Neuhauser H K. Epidemiology of vertigo. Curr Opin Neurol. 2007; 20(1) 40-46
21 Neuhauser H K, Radtke A, von Brevern M et al.. Migrainous vertigo: prevalence and impact on quality of life. Neurology. 2006; 67(6) 1028-1033
22 Kayan A, Hood J D. Neuro-otological manifestations of migraine. Brain. 1984; 107(Pt 4) 1123-1142
23 Battista R A. Audiometric findings of patients with migraine-associated dizziness. Otol Neurotol. 2004; 25(6) 987-992
24 Committee on Hearing and Equilibrium Guidelines for the Diagnosis and Evaluation of Therapy in Menière's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg. 1995; 113(3) 181-185
25 Basser L S. Benign paroxysmal vertigo of childhood (a variety of vestibular neuronitis). Brain. 1964; 87 141-152
26 Fenichel G M. Migraine as a cause of benign paroxysmal vertigo of childhood. J Pediatr. 1967; 71(1) 114-115
27 Lanzi G, Balottin U, Fazzi E, Rosano F B. The periodic syndrome in pediatric migraine sufferers. Cephalalgia. 1983; 3(Suppl 1) 91-93
28 Lanzi G, Balottin U, Fazzi E, Tagliasacchi M, Manfrin M, Mira E. Benign paroxysmal vertigo of childhood: a long-term follow-up. Cephalalgia. 1994; 14(6) 458-460
29 Drigo P, Carli G, Laverda A M. Benign paroxysmal vertigo of childhood. Brain Dev. 2001; 23(1) 38-41
30 Abu-Arafeh I, Russell G. Paroxysmal vertigo as a migraine equivalent in children: a population-based study. Cephalalgia. 1995; 15(1) 22-25, discussion 4
31 Marcelli V, Piazza F, Pisani F, Marciano E. Neuro-otological features of benign paroxysmal vertigo and benign paroxysmal positioning vertigo in children: a follow-up study. Brain Dev. 2006; 28(2) 80-84
32 Headache Classification Subcommittee of the International Headache Society . The international classification of headache disorders, 2nd Ed. Cephalalgia. 2004; 24(Suppl 1) 1-160
33 Wang C T, Lai M S, Young Y H. Relationship between basilar-type migraine and migrainous vertigo. Headache. 2009; 49(3) 426-434
34 Eviatar L. Vestibular testing in basilar artery migraine. Ann Neurol. 1981; 9(2) 126-130
35 Olsson J E. Neurotologic findings in basilar migraine. Laryngoscope. 1991; 101(1 Pt 2, Suppl 52) 1-41
36 Perez-Garrigues H, Lopez-Escamez J A, Perez P et al.. Time course of episodes of definitive vertigo in Meniere's disease. Arch Otolaryngol Head Neck Surg. 2008; 134(11) 1149-1154
37 Rassekh C H, Harker L A. The prevalence of migraine in Menière's disease. Laryngoscope. 1992; 102(2) 135-138
38 Parker W. Menière's disease. Etiologic considerations. Arch Otolaryngol Head Neck Surg. 1995; 121(4) 377-382
39 Hinchcliffe R. Headache and Menière's disease. Acta Otolaryngol. 1967; 63(4) 384-390
40 Radtke A, Lempert T, Gresty M A, Brookes G B, Bronstein A M, Neuhauser H. Migraine and Ménière's disease: is there a link?. Neurology. 2002; 59(11) 1700-1704
41 Cha Y H, Brodsky J, Ishiyama G, Sabatti C, Baloh R W. The relevance of migraine in patients with Meńière's disease. Acta Otolaryngol. 2007; 127(12) 1241-1245
42 Cha Y H, Kane M J, Baloh R W. Familial clustering of migraine, episodic vertigo, and Ménière's disease. Otol Neurotol. 2008; 29(1) 93-96
43 Johnson G D. Medical management of migraine-related dizziness and vertigo. Laryngoscope. 1998; 108(1 Pt 2) 1-28
44 Reploeg M D, Goebel J A. Migraine-associated dizziness: patient characteristics and management options. Otol Neurotol. 2002; 23(3) 364-371
45 Bir L S, Ardiç F N, Kara C O, Akalin O, Pinar H S, Celiker A. Migraine patients with or without vertigo: comparison of clinical and electronystagmographic findings. J Otolaryngol. 2003; 32(4) 234-238
46 Kuritzky A, Toglia U J, Thomas D. Vestibular function in migraine. Headache. 1981; 21(3) 110-112
47 Zhou G, Cox L C. Vestibular evoked myogenic potentials: history and overview. Am J Audiol. 2004; 13(2) 135-143
48 Welgampola M S, Colebatch J G. Characteristics and clinical applications of vestibular-evoked myogenic potentials. Neurology. 2005; 64(10) 1682-1688
49 Liao L-J, Young Y-H. Vestibular evoked myogenic potentials in basilar artery migraine. Laryngoscope. 2004; 114(7) 1305-1309
50 Chen C-H, Young Y-H. Vestibular evoked myogenic potentials in brainstem stroke. Laryngoscope. 2003; 113(6) 990-993
51 Allena M, Magis D, De Pasqua V, Schoenen J, Bisdorff A R. The vestibulo-collic reflex is abnormal in migraine. Cephalalgia. 2007; 27(10) 1150-1155
52 Roceanu A, Allena M, De Pasqua V, Bisdorff A, Schoenen J. Abnormalities of the vestibulo-collic reflex are similar in migraineurs with and without vertigo. Cephalalgia. 2008; 28(9) 988-990
53 von Brevern M, Zeise D, Neuhauser H, Clarke A H, Lempert T. Acute migrainous vertigo: clinical and oculographic findings. Brain. 2005; 128(Pt 2) 365-374
54 Lee H, Jen J C, Cha Y H, Nelson S F, Baloh R W. Phenotypic and genetic analysis of a large family with migraine-associated vertigo. Headache. 2008; 48(10) 1460-1467
55 Lee H, Sininger L, Jen J C, Cha Y H, Baloh R W, Nelson S F. Association of progesterone receptor with migraine-associated vertigo. Neurogenetics. 2007; 8(3) 195-200
56 von Brevern M, Ta N, Shankar A et al.. Migrainous vertigo: mutation analysis of the candidate genes CACNA1A, ATP1A2, SCN1A, and CACNB4. Headache. 2006; 46(7) 1136-1141
57 Viirre E S, Baloh R W. Migraine as a cause of sudden hearing loss. Headache. 1996; 36(1) 24-28
58 Lee H, Whitman G T, Lim J G et al.. Hearing symptoms in migrainous infarction. Arch Neurol. 2003; 60(1) 113-116
59 Tippin J, Corbett J J, Kerber R E, Schroeder E, Thompson H S. Amaurosis fugax and ocular infarction in adolescents and young adults. Ann Neurol. 1989; 26(1) 69-77
60 Winterkorn J M, Kupersmith M J, Wirtschafter J D, Forman S. Brief report: treatment of vasospastic amaurosis fugax with calcium-channel blockers. N Engl J Med. 1993; 329(6) 396-398
61 Kruit M, van Buchem M, Launer L, Terwindt G, Ferrari M. Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia. 2009; , Jun 8. (Epub ahead of print)
62 Ohno K, Takeda N, Yamano M, Matsunaga T, Tohyama M. Coexistence of acetylcholine and calcitonin gene-related peptide in the vestibular efferent neurons in the rat. Brain Res. 1991; 566(1-2) 103-107
63 Sewell W F, Starr P A. Effects of calcitonin gene-related peptide and efferent nerve stimulation on afferent transmission in the lateral line organ. J Neurophysiol. 1991; 65(5) 1158-1169
64 Ho T W, Mannix L K, Fan X MK-0974 Protocol 004 study group et al. Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology. 2008; 70(16) 1304-1312
65 Zajonc T P, Roland P S. Vertigo and motion sickness. Part II: Pharmacologic treatment. Ear Nose Throat J. 2006; 85(1) 25-35
66 Neuhauser H, Radtke A, von Brevern M, Lempert T. Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial. Neurology. 2003; 60(5) 882-883
67 Marcus D A, Furman J M. Prevention of motion sickness with rizatriptan: a double-blind, placebo-controlled pilot study. Med Sci Monit. 2006; 12(1) PI1-PI7
68 Maione A. Migraine-related vertigo: diagnostic criteria and prophylactic treatment. Laryngoscope. 2006; 116 1782-1786
69 Carmona S, Settecase N. Use of topiramate (topamax) in a subgroup of migraine-vertigo patients with auditory symptoms. Ann N Y Acad Sci. 2005; 1039 517-520
70 Bisdorff A R. Treatment of migraine related vertigo with lamotrigine an observational study. Bull Soc Sci Med Grand Duche Luxemb. 2004; (2) 103-108
71 Lampl C, Buzath A, Klinger D, Neumann K. Lamotrigine in the prophylactic treatment of migraine aura—a pilot study. Cephalalgia. 1999; 19(1) 58-63
72 D'Andrea G, Granella F, Cadaldini M, Manzoni G C. Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study. Cephalalgia. 1999; 19(1) 64-66
73 Ophoff R A, Terwindt G M, Vergouwe M N et al.. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 1996; 87(3) 543-552
74 Jen J, Kim G W, Baloh R W. Clinical spectrum of episodic ataxia type 2. Neurology. 2004; 62(1) 17-22
75 Zasorin N L, Baloh R W, Myers L B. Acetazolamide-responsive episodic ataxia syndrome. Neurology. 1983; 33(9) 1212-1214
76 Calandriello L, Veneziano L, Francia A et al.. Acetazolamide-responsive episodic ataxia in an Italian family refines gene mapping on chromosome 19p13. Brain. 1997; 120(Pt 5) 805-812
77 Baloh R W, Foster C A, Yue Q, Nelson S F. Familial migraine with vertigo and essential tremor. Neurology. 1996; 46(2) 458-460
78 Rascol O, Hain T C, Brefel C, Benazet M, Clanet M, Montastruc J L. Antivertigo medications and drug-induced vertigo. A pharmacological review. Drugs. 1995; 50(5) 777-791
79 Rascol O, Clanet M, Montastruc J L. Calcium antagonists and the vestibular system: a critical review of flunarizine as an antivertigo drug. Fundam Clin Pharmacol. 1989; 3(Suppl) 79s-87s
80 Iwasaki S, Ushio M, Chihara Y, Ito K, Sugasawa K, Murofushi T. Migraine-associated vertigo: clinical characteristics of Japanese patients and effect of lomerizine, a calcium channel antagonist. Acta Otolaryngol Suppl. 2007; (559) 45-49
81 Schmidt J T, Huizing E H. The clinical drug trial in Menière's disease with emphasis on the effect of betahistine SR. Acta Otolaryngol Suppl. 1992; 497 1-189
82 Brandt T, Zwergal A, Strupp M. Medical treatment of vestibular disorders. Expert Opin Pharmacother. 2009; 10(10) 1537-1548
83 de Bock G H, Eelhart J, van Marwijk H W, Tromp T P, Springer M P. A postmarketing study of flunarizine in migraine and vertigo. Pharm World Sci. 1997; 19(6) 269-274
84 Whitney S L, Wrisley D M, Brown K E, Furman J M. Physical therapy for migraine-related vestibulopathy and vestibular dysfunction with history of migraine. Laryngoscope. 2000; 110(9) 1528-1534
85 Wrisley D M, Whitney S L, Furman J M. Vestibular rehabilitation outcomes in patients with a history of migraine. Otol Neurotol. 2002; 23(4) 483-487
86 Best C, Eckhardt-Henn A, Tschan R, Dieterich M. Psychiatric morbidity and comorbidity in different vestibular vertigo syndromes. Results of a prospective longitudinal study over one year. J Neurol. 2009; 256(1) 58-65
87 Eckhardt-Henn A, Best C, Bense S et al.. Psychiatric comorbidity in different organic vertigo syndromes. J Neurol. 2008; 255(3) 420-428

Yoon-Hee ChaM.D.

Visiting Assistant Professor, Department of Neurology, University of California Los Angeles

710 Westwood Plaza, Box 951769, Los Angeles, CA 90095

eMail: yhcha@mednet.ucla.edu